Onkolytische Viren als innovativer Ansatz in der Therapie gastrointestinaler Tumoren = Oncolytic viruses for genetic therapy of gastrointestinal tumorsBITZER, M; LAUER, U. M.Zeitschrift für Gastroenterologie. 2003, Vol 41, Num 7, pp 667-674, issn 0044-2771, 8 p.Article

Telomerase-dependent oncolytic adenovirus for cancer treatmentHUANG, T-G; SAVONTAUS, M. J; SHINOZAKI, K et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 15, pp 1241-1247, issn 0969-7128, 7 p.Article

Nonviral vectors for cancer gene therapy : Prospects for integrating vectors and combination therapiesOHIFEST, John R; FREESE, Andrew B; LARGAESPADA, David A et al.Current gene therapy. 2005, Vol 5, Num 6, pp 629-641, issn 1566-5232, 13 p.Article

Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapyGARDLIK, R; BEHULIAK, M; PALFFY, R et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 5, pp 425-431, issn 0969-7128, 7 p.Article

A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replicationFECHNER, Henry; XIAOMIN WANG; HURTADO PICO, Almudena et al.Journal of biotechnology. 2007, Vol 127, Num 4, pp 560-574, issn 0168-1656, 15 p.Article

Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapyINGRAM, N; PORTER, C. D.Gene therapy (Basingstoke). 2005, Vol 12, Num 13, pp 1058-1069, issn 0969-7128, 12 p.Article

Paired-like homeoprotein ESXR1 acts as a sequence-specific transcriptional repressor of the human K-ras geneYANAGIHARA, Masatomo; ISHIKAWA, Susumu; NAITO, Masanori et al.Oncogene (Basingstoke). 2005, Vol 24, Num 38, pp 5878-5887, issn 0950-9232, 10 p.Article

Serum-resistant lipopolyplexes for gene delivery to liver tumour cellsGARCIA, Leire; BUNUALES, Maria; DÜZGÜNES, Nejat et al.European journal of pharmaceutics and biopharmaceutics. 2007, Vol 67, Num 1, pp 58-66, issn 0939-6411, 9 p.Article

Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in miceLASEK, Witold; BASAK, Grzegorz; JAKOBISIAK, Marek et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 4, pp 363-372, issn 0340-7004, 10 p.Article

Current strategies in cancer gene therapyEL-ANEED, Anas.European journal of pharmacology. 2004, Vol 498, Num 1-3, pp 1-8, issn 0014-2999, 8 p.Article

Viral delivery for gene therapy against cell movement in cancerWU, Te-Lang; DONGMING ZHOU.Advanced drug delivery reviews. 2011, Vol 63, Num 8, pp 671-677, issn 0169-409X, 7 p.Article

Cell and gene therapy using mesenchymal stem cells (MSCs)OZAWA, Keiya; SATO, Kazuya; MIZUKAMI, Hiroaki et al.Journal of autoimmunity (Print). 2008, Vol 30, Num 3, pp 121-127, issn 0896-8411, 7 p.Conference Paper

Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigensKUROKI, Masahide; KUROKI, Motomu; SHIBAGUCHI, Hirotomo et al.Anticancer research. 2004, Vol 24, Num 5C, pp 3373-3377, issn 0250-7005, 5 p.Conference Paper

Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymersKIM, Jaesung; KIM, Pyung-Hwan; HYE YEONG NAM et al.Journal of controlled release. 2012, Vol 158, Num 3, pp 451-460, issn 0168-3659, 10 p.Article

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell culturesDIAS, João D; GUS, Kilian; PESONEN, Sari et al.European journal of cancer (1990). 2010, Vol 46, Num 3, pp 625-635, issn 0959-8049, 11 p.Article

Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: Effects of combining beneficial single mutationsJABERIPOUR, Mansooreh; VASS, Simon O; GUISE, Christopher P et al.Biochemical pharmacology. 2010, Vol 79, Num 2, pp 102-111, issn 0006-2952, 10 p.Article

Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomesFANECA, H; FAUSTINO, A; PEDROSO DE LIMA, M. C et al.Journal of controlled release. 2008, Vol 126, Num 2, pp 175-184, issn 0168-3659, 10 p.Article

Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligandsPEDERSEN, Nina; HANSEN, Susan; HEYDENREICH, Annette V et al.European journal of pharmaceutics and biopharmaceutics. 2006, Vol 62, Num 2, pp 155-162, issn 0939-6411, 8 p.Article

Eukaryotic expression vectors containing genes encoding plant proteins for killing of cancer cellsGLINKA, Elena M.Cancer epidemiology (Print). 2013, Vol 37, Num 6, pp 1014-1019, issn 1877-7821, 6 p.Article

ADENOVIRAL E4ORF3 AND E4ORF6 PROTEINS, BUT NOT E1B55K, INCREASE KILLING OF CANCER CELLS BY RADIOTHERAPY IN VIVOLIIKANEN, Ilkka; DIAS, João D; AHTIAINEN, Laura et al.International journal of radiation oncology, biology, physics. 2010, Vol 78, Num 4, pp 1201-1209, issn 0360-3016, 9 p.Article

Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor modelsMORISHIGE, Tomohiro; YOSHIOKA, Yasuo; TANABE, Aya et al.International immunopharmacology (Print). 2010, Vol 10, Num 1, pp 26-33, issn 1567-5769, 8 p.Article

Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cellsKE DONG; RUI WANG; XI WANG et al.Breast cancer research and treatment. 2009, Vol 113, Num 3, pp 443-456, issn 0167-6806, 14 p.Article

Recombinant polymers for cancer gene therapy : A minireviewHAIDER, M; HATEFI, A; GHANDEHARI, H et al.Journal of controlled release. 2005, Vol 109, Num 1-3, pp 108-119, issn 0168-3659, 12 p.Conference Paper

The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cellsPIETERSEN, Alexandra M; RUTJES, Saskia A; VAN TONGEREN, Joost et al.Journal of molecular medicine (Berlin. Print). 2004, Vol 82, Num 1, pp 56-63, issn 0946-2716, 8 p.Article

Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposureSUZUKI, Ryo; NAMAI, Eisuke; NAKAGAWA, Shinsaku et al.Journal of controlled release. 2010, Vol 142, Num 2, pp 245-250, issn 0168-3659, 6 p.Article